...
首页> 外文期刊>Journal of Clinical Microbiology >Identification of the innate human immune response to surface-exposed proteins of coagulase-negative staphylococci.
【24h】

Identification of the innate human immune response to surface-exposed proteins of coagulase-negative staphylococci.

机译:鉴定人类对凝固酶阴性葡萄球菌表面暴露蛋白的天然免疫反应。

获取原文
           

摘要

The presumed host defense against coagulase-negative staphylococci (ConS), recognized pathogens in hosts with compromised immunity or indwelling medical devices, is opsonophagocytosis. Targets for opsonization remain unclear. Using radiolabeling techniques, we identified the surface-exposed proteins of ConS and determined the innate humoral immune responses to them among healthy adults. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of surface proteins extrinsically labeled with 125I demonstrated 20 to 30 proteins with molecular weights of 15,000 to greater than 130,000. Five to ten of these proteins were immunogenic and recognized by normal human sera, including predominant 18-, 41-, 48-, and 51-kDa proteins. We also evaluated the humoral response of cancer patients with ConS bacteremia. Patients' sera obtained before bacteremic episodes demonstrated a pattern of reactivity similar to that of normal human sera. When patients' sera obtained after bacteremic episodes were used to determine whether an expanded immune response followed infection, only one of seven showed reactivity with more proteins than seen with the innate response. Western blot (immunoblot) analysis and whole-cell enzyme-linked immunosorbent assays were also evaluated. This study identifies (i) the surface-exposed proteins available for host interaction, (ii) the innate human antibody response to these proteins, and (iii) the immune response of cancer patients with ConS bacteremia.
机译:假定的宿主抵抗凝结酶阴性葡萄球菌(ConS)的能力是调理吞噬作用,ConS是免疫力受损或医疗设备留置的宿主中公认的病原体。调理作用的目标仍然不清楚。使用放射性标记技术,我们确定了ConS表面暴露的蛋白质,并确定了健康成年人中对其的先天体液免疫应答。用125 I外源标记的表面蛋白的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳显示,分子量为15,000至130,000以上的蛋白有20至30种。这些蛋白中有五到十种具有免疫原性,并能被正常人的血清识别,包括主要的18-,41-,48-和51-kDa蛋白。我们还评估了患有ConS菌血症的癌症患者的体液反应。在细菌发作之前获得的患者血清显示出与正常人血清相似的反应模式。当使用细菌发作后获得的患者血清确定感染后是否发生了扩大的免疫反应时,只有七分之一的人表现出比先天反应更多的蛋白质反应。还评估了蛋白质印迹(免疫印迹)分析和全细胞酶联免疫吸附测定。这项研究确定(i)可用于宿主相互作用的表面暴露蛋白,(ii)对这些蛋白的先天人类抗体反应,以及(iii)患有ConS菌血症的癌症患者的免疫反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号